Monographie - Pentostatin

Pentostatin

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Nipent

Almanya, Amerika Birleşik Devletleri, Büyük Britanya, Fransa, Hollanda, İrlanda, İspanya, İtalya, Portekiz, Slovenya, yeni Zelanda, Yunanistan

Kaynaklar : Pentostatin

	tip	yayın
154	Dergi	Al-Razzak LA, Benedetti AE, Waugh WN, Stella VJ. Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent. Pharm Res 1990 ; 7: 452-460.
169	Dergi	Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1993 ; 50: 2359-2363.
248	Dergi	Trissel LA, Martinez JF. Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection. Am J Hosp Pharm 1993 ; 50: 300-304.
334	Dergi	Trissel LA, Tramonte SM, Grilley BJ. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 988-992.
335	Dergi	Trissel LA, Bready BB, Kwan JW, Santiago NM. Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection. Am J Hosp Pharm 1992 ; 49: 402-406.
492	Dergi	Trissel LA, Parks NPT, Santiago NM. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 2186-2189.
4999	Laboratuar	NIPENT 10 mg, poudre pour solution pour injection, poudre pour solution pour perfusion - Résumé des caractéristiques du produit. PFIZER HOLDING FRANCE 2024